Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 72INDUSTRY 23NIH 9OTHER_GOV 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 1

Interventions

Cisplatin 24Radiotherapy 18Carboplatin 18Paclitaxel 17Vincristine 15Cyclophosphamide 14Etoposide 13Filgrastim 12Doxorubicin 12Gemcitabine 11Temozolomide 10Cytarabine 9Topotecan 8Docetaxel 8Methotrexate 7Irinotecan 7Granulocyte Colony-Stimulating Factor 7Dexamethasone 7Taxes 6Radiation 6Peripheral Blood Stem Cell Transplantation 6Radiotherapy, Conformal 5Oxaliplatin 5Melphalan 5Fenretinide 5Chemotherapy, Adjuvant 5Capecitabine 5etoposide phosphate 4Trastuzumab 4Platinum 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × NETWORK × Interleukin-2 × Clear all
NCT00009698 2013-06-28

Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Children's Oncology Group

Phase 1 Completed
1 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡